Get Real Time Here
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open3.400 | Close- |
| Vol / Avg.559.941K / 2.353M | Mkt Cap166.301M |
| Day Range3.220 - 3.405 | 52 Wk Range3.080 - 21.880 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | -1.060 | -0.5900 | ||||
| REV | 217.030M | 337.900M | 120.870M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-29 | Benchmark | Robert Wasserman | Downgrades | BuyHold | - | - | - |
| 2023-05-31 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-05-19 | Benchmark | Robert Wasserman | Reiterates | BuyBuy | Maintains | - | 22.00 |
| 2023-04-10 | Benchmark | Robert Wasserman | Upgrades | HoldBuy | Announces | - | 22.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| EBS | Emergent BioSolutions | -5.59% | 166.3M |
| ORTX | Orchard Therapeutics | 2.2% | 179.5M |
| VAXX | Vaxxinity | -5.84% | 163.5M |
| CARM | CARISMA Therapeutics | 1.89% | 173.6M |
| LRMR | Larimar Therapeutics | -3.42% | 165.1M |
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Larimar Therapeutics (NASDAQ:LRMR) and Fusion Pharmaceuticals (NASDAQ:FUSN).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $3.21 last updated Today at October 2, 2023 at 5:33 PM UTC.
Does Emergent BioSolutions (EBS) pay a dividend?
There is no dividend information for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.